Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome

[1]  K. Ohashi,et al.  Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically , 2018, Nephrology.

[2]  Jie Ding,et al.  Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group. , 2018, Kidney international.

[3]  Ituro Inoue,et al.  Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel , 2017, Clinical and Experimental Nephrology.

[4]  E. Ars,et al.  X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations , 2016, PloS one.

[5]  K. Nakanishi,et al.  Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[6]  D. Abrahamson.  Steps on the Alport path to proteinuria. , 2016, Kidney international.

[7]  L. Maquat,et al.  Nonsense-mediated mRNA decay in humans at a glance , 2016, Journal of Cell Science.

[8]  K. Voskarides,et al.  Frequency of COL4A3/COL4A4 Mutations amongst Families Segregating Glomerular Microscopic Hematuria and Evidence for Activation of the Unfolded Protein Response. Focal and Segmental Glomerulosclerosis Is a Frequent Development during Ageing , 2014, PloS one.

[9]  K. Nakanishi,et al.  Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. , 2014, Kidney international.

[10]  R. Korstanje,et al.  A mouse collagen4α4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers , 2013, Kidney international.

[11]  M. Gubler,et al.  The renal lesions of Alport syndrome. , 2009, Journal of the American Society of Nephrology : JASN.

[12]  A. Amoroso,et al.  Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  K. Kyriacou,et al.  COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.

[14]  P. S. St. John,et al.  Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects. , 2007, Journal of the American Society of Nephrology : JASN.

[15]  C. Kashtan.  Alport syndrome and the X chromosome: implications of a diagnosis of Alport syndrome in females. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  B. Beirowski,et al.  Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.

[17]  A. Renieri,et al.  Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. , 2004, Kidney international.

[18]  K. Tryggvason,et al.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen. , 2003, The New England journal of medicine.

[19]  P. Thorner,et al.  Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent. , 2001, Journal of the American Society of Nephrology : JASN.

[20]  R. Kalluri,et al.  Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. , 1997, The Journal of clinical investigation.